|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
Here's Why Pi Network's Token Price Is Pumping
May 11, 2025 at 10:00 pm

Pi Network’s token price has been on a roll today, notching up a 60% price surge. The token is now up to $1.11, a new high for the recent price action.
Volume has also spiked more than 167% in the last 24 hours, making it one of the biggest daily moves for Pi Network.
Crypto expert Justin Wu highlighted the rapid price recovery.
And just like that. $pi roaring back to almost a dollar. What do you think the @PiCoreTeam has to share during Consensus Conference? #pinerwork #pioneer
The Pi Core Team is set to make an ‘ecosystem-related’ announcement on May 14 at the Consensus Conference. Traders are preparing for this event, which is propelling the Pi Coin price.
While there’s no official word yet on the nature of the news, members of the community have been discussing several possibilities.
This won’t be a regular update. Rather, it is being described as an ‘ecosystem-level’ development. This suggests that it may involve structural upgrades or integrations that could affect the broader utility and functionality of the Pi Network.
Among the possibilities being discussed are the introduction of a full-fledged app ecosystem. This could feature decentralized applications, games, and tools that utilize Pi Coin as a transaction medium.
Another scenario involves bringing real-world utility to Pi Coin, such as enabling the purchase of goods or services using the token. Additionally, there could be improvements to the Pi wallet or migration options. This might include faster verification systems or more efficient mainnet tools.
There is also chatter about possibly shifting more control to the community through a DAO.
The strong move in price and volume showcases the growing market anticipation ahead of the announcement. Several traders are entering positions in anticipation of news that could expand Pi Coin’s real-world use cases or technological capabilities.
However, there are no official details yet from the Pi Core Team. Until then, the community speculation continues. The coming days will reveal if this rally has more room to run or if traders will begin taking profits from the recent gains.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































